Student Affairs Announcement
The Ministry of Education, Department of Elementary and Secondary Education will implement the "2026-2027 COVID-19 Vaccination Program" starting from October 1, 2026.
{{ $t('FEZ002') }} Student Affairs Office|
| Subject: | Attached is the "2026-2027 COVID-19 Vaccination Plan" implemented by the Ministry of Education's National and Preschool Education Administration from October 1, 2026. Please acknowledge receipt. |
| Details: |
| 1. | In accordance with the Ministry of Education's National and Preschool Education Administration's letter Tai Jiao Guo Shu Ti Zi No. 1150073044A dated August 6, 2026. |
| 2. | To address the continuous mutation of the COVID-19 virus, and based on the recommendations from the World Health Organization (WHO), the European Union, the United States, and Japan regarding the antigen composition of COVID-19 vaccines for 2026-2027 announced in May 2026, the "Advisory Committee on Immunization Practices (ACIP) of the Ministry of Health and Welfare's Communicable Disease Control Institute" resolved at its meeting on June 24, 2026, to prioritize the use of the XFG COVID-19 vaccine in the aforementioned vaccination plan, in order to enhance the public's immune protection against dominant virus strains. |
| 3. | In accordance with WHO and international vaccination recommendations, the Ministry of Health and Welfare will commence COVID-19 and influenza vaccinations concurrently in two phases starting October 1, 2026. The schedule and eligible recipients are as follows: |
| (1) | Phase 1 (from October 1, 2026): |
| 1. | Elderly individuals aged 65 and above. |
| 2. | Indigenous individuals aged 55 and above. |
| 3. | Care recipients in nursing homes, long-term care facilities (services), and their staff. |
| 4. | Pregnant women. |
| 5. | High-risk individuals aged 6 months and above, including those who meet the criteria for publicly funded influenza vaccination high-risk individuals (patients with chronic diseases, BMI ≥ 30, patients with rare diseases and major illnesses), as well as patients with tuberculosis, disabilities (ADHD, cerebral palsy, congenital defects, developmental or learning disorders, spinal cord injury), mental illnesses (mood disorders, schizophrenia), and dementia. |
| 6. | Medical and public health personnel. |
| 7. | Staff of kindergartens and childcare centers, and home-based childcare providers (nannies). |
| 8. | Parents or actual caregivers of infants under 6 months of age. |
| 9. | Children aged 6 months to under 6 years who have never received a COVID-19 vaccine. |
| (2) | Phase 2 (from November 2, 2026): Adults aged 50-64 without high-risk conditions. |
| 4. |
{{ $t('FEZ012') }} {{ $t('FEZ003') }} Invalid date {{ $t('FEZ014') }} Invalid date| {{ $t('FEZ004') }} 2026-08-11| {{ $t('FEZ005') }} 76| |